Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 20142028)

1.

Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP.

Wang Y, Moreira Mda C, Heringer-Walther S, Ebermann L, Schultheiss HP, Wessel N, Siems WE, Walther T.

J Card Fail. 2010 Feb;16(2):157-63. doi: 10.1016/j.cardfail.2009.09.005. Epub 2009 Nov 4.

PMID:
20142028
2.

Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation.

Moreira Mda C, Heringer-Walther S, Wessel N, Moreira Ventura T, Wang Y, Schultheiss HP, Walther T.

Cardiology. 2008;110(4):217-25. Epub 2007 Dec 12.

PMID:
18073475
3.

Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides.

Moreira Mda C, Wang Y, Heringer-Walther S, Wessel N, Walther T.

Congest Heart Fail. 2009 Mar-Apr;15(2):75-81. doi: 10.1111/j.1751-7133.2009.00051.x.

PMID:
19379453
4.

Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.

Wang Y, Moreira Mda C, Heringer-Walther S, Schultheiss HP, Siems WE, Wessel N, Walther T.

J Cardiovasc Pharmacol. 2010 Jan;55(1):62-6. doi: 10.1097/FJC.0b013e3181c37dc2.

PMID:
20090473
5.

BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.

Falcão LM, Pinto F, Ravara L, van Zwieten PA.

J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):121-9.

PMID:
15526247
6.

Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?

Heringer-Walther S, Moreira Mda C, Wessel N, Wang Y, Ventura TM, Schultheiss HP, Walther T.

J Cardiovasc Pharmacol. 2006 Dec;48(6):293-8.

PMID:
17204908
7.

Beta blockers prevent correlation of plasma ACE2 activity with echocardiographic parameters in patients with idiopathic dilated cardiomyopathy.

Wang Y, Moreira Mda C, Heringer-Walther S, Schultheiss HP, Siems WE, Wessel N, Walther T.

J Cardiovasc Pharmacol. 2015 Jan;65(1):8-12. doi: 10.1097/FJC.0000000000000156.

PMID:
25165996
8.

Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.

Palmer BR, Pilbrow AP, Yandle TG, Frampton CM, Richards AM, Nicholls MG, Cameron VA.

J Am Coll Cardiol. 2003 Mar 5;41(5):729-36.

PMID:
12628714
9.

B-type natriuretic peptide levels in obese patients with advanced heart failure.

Horwich TB, Hamilton MA, Fonarow GC.

J Am Coll Cardiol. 2006 Jan 3;47(1):85-90. Epub 2005 Dec 15.

10.

Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.

Selvais PL, Robert A, Ahn S, van Linden F, Ketelslegers JM, Pouleur H, Rousseau MF.

J Card Fail. 2000 Sep;6(3):201-7.

PMID:
10997745
11.

[BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].

Valle R, Aspromonte N, Carbonieri E, De Michele G, Di Tano G, Giovinazzo P, Cioè R, Di Giacomo T, Milani L, Noventa F, Chiatto M.

Monaldi Arch Chest Dis. 2007 Sep;68(3):154-64. Italian.

PMID:
18361212
12.

Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.

Batlle M, Roig E, Perez-Villa F, Lario S, Cejudo-Martin P, García-Pras E, Ortiz J, Roqué M, Orús J, Rigol M, Heras M, Ramírez J, Jimenez W.

J Heart Lung Transplant. 2006 Sep;25(9):1117-25. Epub 2006 Aug 9.

PMID:
16962475
13.

Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.

Passino C, Pingitore A, Landi P, Fontana M, Zyw L, Clerico A, Emdin M, Iervasi G.

J Card Fail. 2009 Feb;15(1):35-40. doi: 10.1016/j.cardfail.2008.08.008. Epub 2008 Oct 4.

PMID:
19181292
14.

[Measurement of human brain natriuretic peptide in patients with Chagas' disease].

Melo RB, Parente GB, Victor EG.

Arq Bras Cardiol. 2005 Feb;84(2):137-40. Epub 2005 Mar 8. Portuguese.

15.

Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambui Cohort Study of Aging.

Lima-Costa MF, Cesar CC, Peixoto SV, Ribeiro AL.

Am J Epidemiol. 2010 Jul 15;172(2):190-6. doi: 10.1093/aje/kwq106. Epub 2010 Jun 25.

16.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

17.

ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects.

Keidar S, Strizevsky A, Raz A, Gamliel-Lazarovich A.

Nephrol Dial Transplant. 2007 Feb;22(2):597-601. Epub 2006 Nov 9.

18.

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.

J Am Coll Cardiol. 2008 Jul 22;52(4):266-72. doi: 10.1016/j.jacc.2008.03.050.

19.

Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.

Freestone B, Gustafsson F, Chong AY, Corell P, Kistorp C, Hildebrandt P, Lip GY.

Chest. 2008 May;133(5):1203-8. doi: 10.1378/chest.07-2557. Epub 2008 Mar 13.

PMID:
18339785
20.

Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system.

Epelman S, Tang WH, Chen SY, Van Lente F, Francis GS, Sen S.

J Am Coll Cardiol. 2008 Aug 26;52(9):750-4. doi: 10.1016/j.jacc.2008.02.088.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk